Physicochemical Properties
| Molecular Formula | C33H38N4O6 |
| Molecular Weight | 586.68 |
| Exact Mass | 586.279 |
| CAS # | 20298-86-6 |
| PubChem CID | 20055378 |
| Appearance | Blue to dark blue solid powder |
| Density | 1.31±0.1 g/cm3 |
| Boiling Point | 892.1±65.0 °C |
| LogP | 3.128 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 10 |
| Heavy Atom Count | 43 |
| Complexity | 1460 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | CCC1=C(C(=NC1=O)/C=C\2/C(=C(/C(=C/C3=C(C(=C(N3)/C=C\4/C(=C/C)/[C@H](C(=O)N4)C)C)CCC(=O)O)/N2)CCC(=O)O)C)C |
| InChi Key | NNMALANKTSRILL-GSZAROSWSA-N |
| InChi Code | InChI=1S/C33H38N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7,13-15,19,34-35H,8-12H2,1-6H3,(H,37,42)(H,38,39)(H,40,41)/b20-7+,24-13-,27-14-,28-15-/t19-/m1/s1 |
| Chemical Name | 3-[(2Z,5Z)-2-[[3-(2-carboxyethyl)-5-[(Z)-[(3E,4R)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Phycocyanobilin (100 μM; 0-250 min) prolongs the induction period by inhibiting methyl linoleate peroxidation [1]. The oxidation of liposomes is inhibited by phycocyanobilin (1 mM; 0-300 min) [1]. |
| ln Vivo | In type 2 diabetic mice, phycocyanobilin (15 mg/kg; po; in diet for 2 weeks) exhibits antioxidant properties[3]. |
| Animal Protocol |
Animal/Disease Models: Male C57BL/Ks J db/db mice, a rodent model for type 2 diabetes[3] Doses: 15 mg/kg Route of Administration: In diet for 2 weeks Experimental Results: Dramatically diminished blood glucose levels. Normalized the increases in urinary 8 -OHdG and 8-epi-PGF2α levels, renal oxidative stress markers evaluated by renal 8-OHdG staining and DHE staining, Nox4 mRNA, and protein expression, as well as the mRNA levels of other NAD(P)H oxidase components, inflammatory markers and HO-1. |
| References |
[1]. Antioxidant activities of phycocyanobilin prepared from Spirulina platensis. Journal of Applied Phycology, 2000, 12: 435-439. [2]. Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer's disease. J Biosci. 2021;46:42. [3]. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15;304(2):R110-20. |
| Additional Infomation | (3E)-phycocyanobilin is a (2R)-phycocyanobilin. It is a conjugate acid of a (3E)-phycocyanobilin(2-). |
Solubility Data
| Solubility (In Vitro) | DMSO: < 1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: 1 mg/mL (1.70 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication (<60°C).  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7045 mL | 8.5225 mL | 17.0451 mL | |
| 5 mM | 0.3409 mL | 1.7045 mL | 3.4090 mL | |
| 10 mM | 0.1705 mL | 0.8523 mL | 1.7045 mL |